EDWARDS LIFESCIENCES CORP
EDWARDS LIFESCIENCES CORP/ US28176E1082 /
EWLS
|
15/11/2024 17:32:14
|
Chg.
+0.03
|
Volume |
Bid17:32:14 |
Demandez à17:32:14 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
63.71EUR
|
+0.05%
|
1
Chiffrre d'affaires: 62.82 |
-Bid taille: - |
-Ask la taille: - |
37.63 Mrd.EUR |
- |
- |
Description de l'entreprise
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.
Conseil d'administration & Conseil de surveillance
| PDG |
| Bernard J. Zovighian |
| Conseil d'administration |
| Scott B. Ullem, Donald E. Bobo Jr., Todd J. Brinton, Daveen Chopra, Dirksen J. Lehman, Jean-Luc Lemercier, Wayne Markowitz, Christine Z. McCauley, Joseph Nuzzolese |
| Conseil de surveillance |
| Michael A. Mussallem, Kieran T. Gallahue, Leslie S. Heisz, Martha H. Marsh, Nicholas J. Valeriani, Paul A. LaViolette, Ramona Sequeira, Steven R. Loranger, Bernard J. Zovighan |
Données de l'entreprise
| Nom: |
Edwards Lifesciences Corp. |
| Adresse: |
One Edwards Way,Irvine, California 92614, USA |
| Téléphone: |
+1-949-250-2500 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
www.edwards.com/ |
| Industrie: |
Biotechnology |
| Secteur: |
Biotechnology |
| Sous-secteur: |
Biotechnology |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
83.04% |
| IPO date: |
03/04/2000 |
